Mather Group’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.64K Sell
148
-16
-10% -$370 ﹤0.01% 1672
2026
Q1
$3.92K Buy
+164
New +$4.01K ﹤0.01% 1615
2025
Q4
Sell
-112
Closed -$2.26K 931
2025
Q3
$2.26K Buy
+112
New +$1.88K ﹤0.01% 1522
2025
Q2
Sell
-32
Closed -$336 930
2025
Q1
$336 Buy
+32
New +$362 ﹤0.01% 1709
2024
Q3
Sell
-156
Closed -$2.54K 1845
2024
Q2
$2.54K Buy
+156
New +$2.49K ﹤0.01% 1821

Other funds holding ELAN

Mather Group's ELAN Position: Q2 2026 in Review

Mather Group reduced its Elanco Animal Health (ELAN) stake by 9.8% in Q2 2026, selling an estimated $370 and leaving 148 shares worth $3.64K. The position accounts for ﹤0.01% of the portfolio, ranked #1672.

Mather Group first reported a position in ELAN in Q2 2024 and has held it in 5 quarters since. The position peaked at $3.92K in Q1 2026. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Mather Group held 148 shares of Elanco Animal Health worth $3.64K as of Q2 2026.
  • Mather Group sold 16 Elanco Animal Health shares in Q2 2026, an estimated $370.
  • Elanco Animal Health made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #1672 holding.
  • Mather Group first reported a position in Elanco Animal Health in Q2 2024 and has held it in 5 quarters since.
  • Mather Group's Elanco Animal Health position peaked at $3.92K in Q1 2026.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.